首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组Sj14-3-3,SjGST及mIL-12/聚乳酸聚乙醇酸共聚物(PLGA)缓释微球对小鼠免疫保护性的研究
引用本文:罗飞,沈继龙,王志成,李敏,郑美娟,罗庆礼,袁小松,储德勇.重组Sj14-3-3,SjGST及mIL-12/聚乳酸聚乙醇酸共聚物(PLGA)缓释微球对小鼠免疫保护性的研究[J].中国人兽共患病杂志,2006,22(11):1017-1021.
作者姓名:罗飞  沈继龙  王志成  李敏  郑美娟  罗庆礼  袁小松  储德勇
作者单位:[1]教育部重要遗传病基因资源利用重点实验室 [2]安徽省重要遗传病基因资源利用重点实验室 [3]安徽医科大学病原生物学教研室,合肥230032
基金项目:国家自然科学基金;国家高技术研究发展计划(863计划)
摘    要:目的研究聚乳酸聚乙醇酸共聚物(PLGA)微球给药系统在血吸虫病分子疫苗中的应用,并探讨rSj14-3-3,rSjGST及mIL-12作为疫苗的协同作用,及mIL-12刺激机体产生CTL和辅助性T细胞(Th)在抗血吸虫病中的作用。方法从pET28a/Sj14-3-3和GST重组质粒中诱导表达rSj14-3-3及rSjGST,过柱纯化。构建真核表达质粒pcDNA3.1(+)mIL-12,并共同包入PLGA缓释微球。对制备的微球进行体外释放,观察其释放速度。分组免疫BALB/c小鼠,进行尾蚴攻击感染实验。在攻击感染6w后,剖杀小鼠,计算各组的减虫率。结果各组的减虫率:单独rSj14-3-3组为27.6%,rSj14-3-3+PcDNA3.1(+)mIL-12组34.9%,rSj14-3-3+PcDNA3.1(+)mIL-12PLGA微球组37.5%,rSj14-3-3与rSjGST混合后+PcDNA3.1(+)mIL-12PLGA微球组38.8%;各组减卵率分别为(按以上组序)35.3%,49.1%,50.5%,和43.1%。结论PLGA微球给药系统可诱导并调节体液与细胞免疫从而增强了疫苗的抗感染,抗生殖作用。但rSj14-3-3和rSjGST抗原之间未表现出协同作用。mIL-12刺激机体产生CTL和辅助性T细胞(Th),在BALB/c鼠抗血吸虫攻击感染发挥作用,增强了疫苗保护作用。

关 键 词:日本血吸虫  分子疫苗  PLGA  免疫  
文章编号:1002-2694(2006)11-1017-05
收稿时间:2006-05-18
修稿时间:2006-07-25

Protective immunity induced by recombinant signaling proteins Sj14-3-3 and SjGST within IL-12/polylactic-co-glycolic acid delayed release microspheres
LUO Fei,SHEN Ji-long,WANG Zhi-cheng,LI Ming,ZHENG Mei-juan,LUO Qing-li,YUAN Xiao-song,CHU De-yong.Protective immunity induced by recombinant signaling proteins Sj14-3-3 and SjGST within IL-12/polylactic-co-glycolic acid delayed release microspheres[J].Chinese Journal of Zoonoses,2006,22(11):1017-1021.
Authors:LUO Fei  SHEN Ji-long  WANG Zhi-cheng  LI Ming  ZHENG Mei-juan  LUO Qing-li  YUAN Xiao-song  CHU De-yong
Institution:The Key Laboratory of Gene Resource Utilization for Severe Diseases Ministry of Education and The Department of Microbiology and Parasitology, Anhui Medical University, Hefei 230032, China
Abstract:In order to evaluate the role of polylactic-co-glycolic acid (PLGA)delayed release microspheres system in the studies of the molecular vaccines for schistosomiasis and the synergistic effect of recombinant Sj14-3-3, SjGST and mIL-12, as well as the effect of CTLs and the Th cells activated by mIL-12 against Schistosoma japonicum, the expressions of recombinant Sj14-3-3 and SjGST were induced from recombinant plasmid pET28a/Sj14-3-3 and SjGST and purified through His Band Purification Kit. To construct the eukaryotic expression plasmid pcDNA3.1(+)mIL-12, BALB/c mice immunized with recombinant Sj14-3-3 and SjGST and plasmid mIL-12/PLGA delayed release microsphere were challenged with cercaria. Six weeks after challenge, mice were sacrificed, and the worm and egg reduction rates were calculated afterwards. It was found that the worm reduction rates of single rSj14-3-3 group, rSj14-3-3 + pcDNA3.1(+)mIL-12 group, rSj14-3-3 + pcDNA3.1(+)mIL-12/PLGA delayed release microsphere group, rSj14-3-3 +rSjGST + pcDNA3.1(+)mIL-12;PLGA /PLGA delayed release microsphere group were 27..6%, 34.9%. 37.5% and 38.8% respectively, while the egg reduction rates in liver tissues of these 4 groups were 35.3%, 49.1%, 50.5% and43.1% respectively. It is concluded that the PLGA delayed release microsphere system can induce and regulate the development of humoral and cell-mediated immunity so as to promote the anti-infectious immunity of vaccines against schistosomiasis, however, there was no synergistic effect between rSj14-3-3 and rSjGST.
Keywords:PLGA
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国人兽共患病杂志》浏览原始摘要信息
点击此处可从《中国人兽共患病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号